Background {#Sec1}
==========

Non-arteritic anterior ischemic optic neuropathy (NAION) is a potential cause of irreversible vision loss, typically occurring in patients over the age of 50 years \[[@CR1]\]. Usually, at presentation one is affected; however, subsequent development of the same condition in the other eye is not uncommon; \[[@CR2]\] occurring in approximately 15% of patients within a 5-year period \[[@CR3]\]. Presumably, having similar optic disk anatomy in both eyes and exposure to the same vasculopathic risk factors may result in bilateral involvement of both optic nerves \[[@CR4], [@CR5]\]. Diabetics and patients who suffered significant visual loss following the first event are at increased risk for bilateral sequential involvement \[[@CR3]\]. Unfortunately, no effective therapy is currently available that can prevent this occurrence. Thus, patients suffering from unilateral NAION are naturally concerned about the imminent possibility of losing vision in their other eye, and are often interested to know if it is possible to predict the visual outcome following the second event, should it occur, based on the initial presentation. Previous studies assessing visual outcome following bilateral NAION reported conflicting conclusions. Some authors found similar vision in affected eyes of the same individual, whereas others reported the opposite. This controversy remains unresolved even today.

In this study, we performed a systematic review and meta-analysis of studies reporting on visual outcome following bilateral NAION in attempt to resolve this conflict. In addition, we analyzed the severity of the first versus the second NAION event.

Methods {#Sec2}
=======

This study was performed in accordance to a predefined protocol adhering to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Mata-Analysis of Observational Studies in Epidemiology (MOOSE).

Eligibility criteria {#Sec3}
--------------------

For this systematic review and meta-analysis, we considered population-based prospective and retrospective studies describing visual acuity and/or visual field assessments following bilateral NAION.

Study selection {#Sec4}
---------------

The analysis covered publications of adult patients (\>18 years old) with bilateral NAION that included data of visual acuity and/or visual field loss of both affected eyes, measured either at presentation or follow-up. Publications were considered suitable for inclusion if they included raw data or statistical analysis. In case of multiple studies possibly reporting on the same population of patients (by the same authors) only the one reporting on the largest cohort of patients was included. Unpublished papers, nonhuman studies, letters to the editor, editorials, reviews, single case reports, studies enrolling children (\<18 years old), and studies with no visual data were excluded from analysis. Studies reporting on bilateral optic neuropathy following Amiodarone use or studies in which it was impossible to ascertain NAION as the cause of visual loss were excluded as well.

Information sources {#Sec5}
-------------------

A systematic literature search was performed by all authors on the PubMed, Ovid, and Google Scholar databases using the medical search headings and open text fields for publications from the last 50 years (January 1st 1966 to May 31st 2016). The reference list of retrieved articles was also searched for suitable papers.

The search terms included: "non-arteritic ischemic optic neuropathy" AND any of the following terms: "sequential", "subsequent", "successive", "consecutive", "second eye", "fellow eye", "bilateral" and "bilaterality". Search criteria were translated according to the language of the database. A total of 112 publications were obtained. Duplicates were excluded by auto- and hand- searching \[[@CR6]\]. All authors independently screened all the retrieved articles for inclusion and exclusion, and any disagreements were discussed and resolved. The Review Manager (RevMan) Computer program (Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012) was used for management of identified records.

Data extraction and risk of bias assessment {#Sec6}
-------------------------------------------

Data collected from each study included: Study title, journal's name, publication year, first author's name, study design, and sample size. Visual acuity was recorded using the logarithm of minimal angle of resolution (Log MAR). Visual field loss was determined by automated perimetry, Goldmann perimetry, or tangent perimetry as long as the same technique was used for all follow-up evaluations, allowing correlation analysis between the two eyes. The correlation coefficient and/or the mean difference of the first and second NAION eyes were collected from studies conducting a statistical analysis. These statistical parameters were also calculated from studies reporting only raw data.

The potential for publication bias of studies reporting on visual outcome following bilateral NIAON was considered to be low because there is no benefit for either finding a strong or poor correlation of visual outcome between the two involved eyes.

Statistical analyses {#Sec7}
--------------------

Meta-analysis was performed using the comprehensive meta-analysis software version 2 (Biostat Inc., Englewood, NJ). All tests were two-tailed and statistical significance was defined at an alpha level below 5%. A separate meta-analysis was conducted for visual acuity and visual field loss. The effect sizes calculated were Pearson's correlation coefficient and standardized mean difference.

Studies heterogeneity was assessed using the I^2^ and Q tests. When I^2^ was greater than 50%, and Q was statistically significant, indicating significant heterogeneity between studies the random effect model was used for calculations. Otherwise the fixed effect model was used.

Results {#Sec8}
=======

Literature search {#Sec9}
-----------------

The literature search and the manual search of references resulted in 118 papers evaluated for meeting inclusion criteria. Following exclusion 10 studies were included in analysis, including 9 retrospective reports and one prospective, randomized clinical trial (Fig. [1](#Fig1){ref-type="fig"}). Most publications were from the United States (*n* = 8), and the remaining two were from Israel, and Greece.Fig. 1Flowchart of studies search, selection and inclusion for meta-analysis

Correlation of visual outcome in both eyes {#Sec10}
------------------------------------------

The correlation coefficient of visual acuity between both eyes of the same patient following bilateral NAION calculated from data provided in 10 studies (Table [1](#Tab1){ref-type="table"}) is statistically significant (*R* = 0.387, *P* \< 0.001, Fig. [2](#Fig2){ref-type="fig"}). Based on data retrieved from 5 studies (Table [2](#Tab2){ref-type="table"}), the correlation coefficient of visual field loss in both eyes after bilateral NAION is also statistically significant (*R* = 0.445, *P* \< 0.001, Fig. [3](#Fig3){ref-type="fig"}).Table 1Studies included in the meta-analysis of visual acuity following bilateral NAIONAuthorYearPublication typeNo. of patientsCorrelation coefficientStatistical Analysis (P or CI)Studies that found correlation in visual outcomeBoone et al. \[[@CR11]\]1996Retrospective230.5220.043Mercado et al. \[[@CR12]\]2012Retrospective860.2760.01Newman et al. \[[@CR3]\]2002Prospective480.36CI 0.08-0.58Studies that found no correlation in visual outcomeWuDunn et al. \[[@CR8]\]1997Retrospective310.19N/AKupersmith et al. \[[@CR10]\]1997Retrospective330.28CI −0.07-0.57Georgiades et al. \[[@CR13]\]1966Retrospective170.26Hayreh et al. \[[@CR9]\]2013Retrospective1740.33CL 0.24-0.40Dotan et al. \[[@CR7]\]2014Retrospective250.2790.176Studies with only raw dataArnold et al. \[[@CR1]\]2013Retrospective1080.3810.227Borchert et al. \[[@CR14]\]1988Retrospective100.5470.339 Fig. 2Correlation meta-analysis of visual acuity in both affected eyes of the same individual following bilateral NAION Fig. 3Correlation meta-analysis of visual field loss in both affected eyes of the same individual following bilateral NAION Table 2Studies included in the meta-analysis of visual field loss following bilateral NAIONAuthorYearPublication typeNo. of patientsVF correlationSig. (P or CI)Studies that found correlation in visual outcomeBoone et al. \[[@CR11]\]1996Retrospective230.6220.039Mercado et al. \[[@CR12]\]2012Retrospective860.50\<0.001Studies that found no correlation in visual outcomeWuDunn et al. \[[@CR8]\]1997Retrospective31−0.05N/AKupersmith et al. \[[@CR10]\]1997Retrospective330.33CI −0.02-0.61Dotan et al. \[[@CR7]\]2014Retrospective250.3120.043

Mean visual loss following first versus second NAION events {#Sec11}
-----------------------------------------------------------

Mean visual acuity and visual field loss following the first NAION event are not significantly different compared with those after the second one (standardized mean difference of visual acuity 0.008, *P* = 0.890, and visual field loss −0.019, *P* = 0.819, Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}).Fig. 4Standardized difference in means of visual acuity following the first versus the second NAION events Fig. 5Standardized difference in means of visual field loss following the first versus the second NAION events

Discussion {#Sec12}
==========

In this study, we conducted a systematic literature review and meta-analysis of visual outcome following bilateral NAION. Our analysis reached similar results for both visual acuity and visual field loss, finding a weak connection in vision in both eyes of the same patient. In addition, it was determined that there is no difference in severity of the first versus the second NAION events.

For patients suffering an event of NAION it is of great personal importance to know whether it is possible to predict the severity of consecutive event in the other eye, should it occur. The largest prospective study to date analyzing visual outcome following bilateral NAION is the "Ischemic Optic Neuropathy Decompression Trial Follow-up Study", \[[@CR3]\] reporting on 128 patients with bilateral NAION; 80 patients had prior NAION in the fellow eye before enrollment, and 48 patients experienced new NAION in their other eye during the course of the study. Bilateral NAION occurred both in patients randomized for optic nerve sheath decompression and in controls. In approximately half of the patients with bilateral NAION visual acuity in both eyes was within three lines of one another; however, in 30% of patients the visual acuity difference between the eyes was greater than 6 lines leading the authors to conclude that predicting visual outcome of the second eye based on initial presentation is problematic. In our meta-analysis we found significant correlations of visual acuity (*R* = 0.387) and visual field loss (*R* = 0.445) in both eyes of the same individual following bilateral NAION; however, they were relatively small, implying a weak similarity in these outcomes in both eyes. Based on these results the calculated coefficient of determination for visual acuity is 0.149 and for visual field loss it is 0.198, indicating that for any given individual less than 15% of visual acuity and 20% of visual field loss in the secondly affected eye can be explained by these outcomes in the firstly affected eye.

These findings support the findings of one of the authors of this meta-analysis (GD) who previously reported that that there is a stronger correlation for visual field loss than for visual acuity following bilateral NAION. In addition, it was reported that the amount retinal nerve fiber layer (RNFL) thinning measured by optical coherence tomography (OCT) is similar in both eyes. \[[@CR7]\]. Since no other studies evaluated RNFL thickness similarity in both eyes following bilateral NAION this parameter was not included in this meta-analysis; and therefore, it is impossible for us to determine whether RNFL thinning is truly similar in both eyes.

Some authors reported that the second NAION event is usually milder as a result of better control of vasculopathic risk factors including initiation of anti-thrombotic therapy following the first event \[[@CR8], [@CR9]\]. On the other hand, others reported similar severity of both NAION events, \[[@CR10]\] and the result of this meta-analysis support these studies.

A major strength of this study is that a comprehensive literature search identified all relevant reports, and the methodological quality of included studies was assessed using objective measures. Its limitations include the relative paucity of literature reports regarding bilateral NAION, and the nature of most studies which were retrospective case series with their inherent limitations of selection bias and availability of accurate and complete data recordings.

Conclusions {#Sec13}
===========

Although a connection exists between visual outcome in both eyes following bilateral NAION the association is small, indicating that it is still impossible to predict with certainty the severity of a successive NAION event based on initial presentation. Patients suffering extensive visual loss following the first event can be advised that the outcome of a subsequent event, should it occur, may be much more favorable. In addition, there is currently insufficient evidence to support a difference in severity of the first versus the second NAION event.
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